Bausch Health Companies | VRX - Ebitda


Bausch Health Companies reported $1.31B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Amgen USD 3.86B 1.28B Mar/2026
ANI Pharmaceuticals USD 71.6M 6.69M Jun/2026
Aurora Cannabis CAD 3.7M 14.78M Mar/2026
Bausch Health Companies USD 1.31B 230M Sep/2026
Biogen USD 450.8M 198.9M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Canopy Growth CAD -137M 134.13M Mar/2026
Corcept Therapeutics USD -49M 53.2M Mar/2026
Danaher USD 2.1B 257M Sep/2026
Drreddys Laboratories INR 8.63B 12.96B Mar/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Novo Nordisk DKK 37.36B 2.64B Jun/2026
Pacira USD 48.67M 8.43M Jun/2026
Perrigo USD 141.6M 1.34B Mar/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 61.24M 23.31M Jun/2026
Supernus Pharmaceuticals USD 55.6M 24M Sep/2026
Vertex Pharmaceuticals USD 1.33B 130.5M Jun/2026
Zoetis USD 939M 0 Mar/2026